Urology

Search results

• Phase 3 CheckMate-274 Meets Primary End Points in Urothelial Carcinoma

  Matthew Galsky,

  25/09/20

  1 item of Media coverage

  Press/Media

• BMS boosted by Opdivo trial success

  Matthew Galsky,

  25/09/20

  1 item of Media coverage

  Press/Media

• Adjuvant nivolumab extends DFS in urothelial carcinoma subset

  Matthew Galsky,

  25/09/20

  1 item of Media coverage

  Press/Media

• Adjuvant Nivolumab Improves DFS in High-Risk Muscle-Invasive Urothelial Carcinoma

  Matthew Galsky,

  25/09/20

  1 item of Media coverage

  Press/Media

• Opdivo (nivolumab) Significantly Improves Disease Free-Survival vs. Placebo as Adjuvant Therapy for Patients with High-Risk, Muscle-Invasive Urothelial Carcinoma in Phase 3 CheckMate -274 Trial

  Matthew Galsky

  24/09/20 → 25/09/20

  15 items of Media coverage

  Press/Media

• Nivolumab improves outcomes as adjuvant treatment in bladder cancer

  Matthew Galsky,

  25/09/20

  1 item of Media coverage

  Press/Media

• Chemistry / M2 Pharma, "Bristol Myers Squibb reports positive Opdivo (nivolumab) trial results."

  Matthew Galsky,

  25/09/20

  1 item of Media coverage

  Press/Media

• Bristol Myers Squibb reports positive Opdivo (nivolumab) trial results

  Matthew Galsky,

  25/09/20

  2 items of Media coverage

  Press/Media

• The Tisch Cancer Institute Earns Second Consecutive Designation from National Cancer Institute.

  Emily Bernstein,, Ramon Parsons,, Nina Bickell, Nina Bhardwaj, Emanuela Taioli, William Oh & Miriam Merad

  24/09/20

  1 item of Media coverage

  Press/Media

• Mount Sinai Health System: The Tisch Cancer Institute Earns Second Consecutive Designation from National Cancer Institute

  Emily Bernstein,, Ramon Parsons,, Nina Bickell, Nina Bhardwaj, Emanuela Taioli, William Oh & Miriam Merad

  24/09/20

  1 item of Media coverage

  Press/Media

• Bristol Myers Squibb: Opdivo (nivolumab) Significantly Improves Disease Free-Survival vs. Placebo as Adjuvant Therapy for Patients with High-Risk, Muscle-Invasive Urothelial Carcinoma in Phase 3 CheckMate -274 Trial

  Matthew Galsky,

  24/09/20

  1 item of Media coverage

  Press/Media

• Opdivo Significantly Improves DFS vs. Placebo as Adjuvant Therapy for Patients with High-Risk, Muscle-Invasive Urothelial Carcinoma

  Matthew Galsky

  24/09/20

  6 items of Media coverage

  Press/Media

• The Tisch Cancer Institute Earns Second Consecutive...

  Ramon Parsons,, William Oh, Emily Bernstein,, Nina Bickell, Nina Bhardwaj, Emanuela Taioli & Miriam Merad

  24/09/20

  8 items of Media coverage

  Press/Media

• Adjuvant nivolumab improves disease-free survival in muscle-invasive urothelial carcinoma

  Matthew Galsky,

  24/09/20

  1 item of Media coverage

  Press/Media

• ADT tied to reduced COVID-19 severity

  William Oh

  29/07/20

  1 item of Media coverage

  Press/Media

• Mount Sinai Expert Guides Gastroenterology

  David Greenwald,, Blair Lewis, Ajai Chari, Antonia New, Stuart Finkel, Waleed Javaid, Robert Hirten, Jawad Ahmad, William Oh, Scott Friedman & Bruce E. Sands

  22/07/20

  1 item of Media coverage

  Press/Media

• SARS-CoV-2 is More Severe in Men, Emerging Data Suggests in New Review by Mount Sinai Researchers

  Ashutosh Tewari

  21/07/20

  1 item of Media coverage

  Press/Media

• Atezolizumab plus chemotherapy improves PFS in metastatic urothelial carcinoma

  Matthew Galsky,

  14/07/20

  1 item of Media coverage

  Press/Media

• HCRN investigators report switch maintenance pembrolizumab leads to additional objective responses, prolongs progression-free survival in some patients with metastatic urothelial cancer

  Matthew Galsky,

  27/06/20

  1 item of Media coverage

  Press/Media

• -Karolinska Institutet: Cell stemness is maintained upon concurrent expression of RB and the mitochondrial ribosomal protein S18-2

  George Klein,

  25/06/20

  1 item of Media coverage

  Press/Media

• One of SW Ohio's largest doctor groups lands private equity deal

  Deepak Kapoor,

  18/06/20

  1 item of Media coverage

  Press/Media

• Lee Equity Invests in Urology Platform

  Deepak Kapoor,

  17/06/20

  1 item of Media coverage

  Press/Media

• One of Greater Cincinnati's largest doctor groups lands private equity deal

  Deepak Kapoor,

  16/06/20

  2 items of Media coverage

  Press/Media

• New York doctor group partners with Ohio practice to form large urological provider in private equity deal

  Deepak Kapoor,

  16/06/20

  1 item of Media coverage

  Press/Media

• Sex hormones signal why virus hits men harder

  William Oh

  4/06/20 → 10/06/20

  2 items of Media coverage

  Press/Media